Literature DB >> 22617110

LNA-based oligonucleotide electrotransfer for miRNA inhibition.

Sophie Chabot1, Julie Orio, Romain Castanier, Elisabeth Bellard, Søren J Nielsen, Muriel Golzio, Justin Teissié.   

Abstract

Micro-RNAs (miRNAs) are small regulatory RNAs that play an important role in disease development and progression and therefore represent a potential new class of therapeutic targets. However, an effective and safe clinical approach for miRNA inhibition remains elusive, primarily due to the lack of effective delivery methods. We proposed to inhibit miRNA by electrotransferring an antisense DNA oligomer containing locked nucleic acids (LNAs) (LNA/DNA oligomer). We observed that electropulsation (EP) led to a strong cellular uptake of LNA/DNA oligomer. The LNA/DNA oligomer electrotransfer mechanism and intracellular localization were visually investigated in real time at the single-cell level. Cyanine 5-labeled oligonucleotide entered exclusively during pulse application on the side of the permeabilized cell membrane facing the cathode, driven by electrophoretic forces. Minutes after the electrotransfer, the LNA/DNA oligomer diffused into the nucleus. EP provided the anti-miRNA oligomer with immediate and direct access to its cytoplasmic mature miRNA target and/or its nuclear precursor miRNA target. We then demonstrated using a LNA/DNA oligomer anti-miR34a that LNA/DNA oligomer electrotransfer decreased the level of the miR34a target and induced its functional inhibition. Our findings show that using the electrotransfer technique for LNA-based oligonucleotide delivery is a promising therapeutic strategy to silence deleterious miRNAs overexpressed in diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22617110      PMCID: PMC3412486          DOI: 10.1038/mt.2012.95

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  50 in total

1.  Rapid electronic detection of probe-specific microRNAs using thin nanopore sensors.

Authors:  Meni Wanunu; Tali Dadosh; Vishva Ray; Jingmin Jin; Larry McReynolds; Marija Drndić
Journal:  Nat Nanotechnol       Date:  2010-10-24       Impact factor: 39.213

Review 2.  The utility of LNA in microRNA-based cancer diagnostics and therapeutics.

Authors:  Jan Stenvang; Asli N Silahtaroglu; Morten Lindow; Joacim Elmen; Sakari Kauppinen
Journal:  Semin Cancer Biol       Date:  2008-01-15       Impact factor: 15.707

3.  The effect of chemical modification and nanoparticle formulation on stability and biodistribution of siRNA in mice.

Authors:  Shan Gao; Frederik Dagnaes-Hansen; Ebbe Juel Bech Nielsen; Jesper Wengel; Flemming Besenbacher; Kenneth Alan Howard; Jørgen Kjems
Journal:  Mol Ther       Date:  2009-04-28       Impact factor: 11.454

Review 4.  Revisiting the principles of microRNA target recognition and mode of action.

Authors:  Peter Brodersen; Olivier Voinnet
Journal:  Nat Rev Mol Cell Biol       Date:  2009-01-15       Impact factor: 94.444

Review 5.  Everything you wanted to know about small RNA but were afraid to ask.

Authors:  Scott D Boyd
Journal:  Lab Invest       Date:  2008-04-21       Impact factor: 5.662

Review 6.  Progress and prospects: nuclear import of nonviral vectors.

Authors:  A P Lam; D A Dean
Journal:  Gene Ther       Date:  2010-03-04       Impact factor: 5.250

Review 7.  Targeting microRNAs in cancer: rationale, strategies and challenges.

Authors:  Ramiro Garzon; Guido Marcucci; Carlo M Croce
Journal:  Nat Rev Drug Discov       Date:  2010-10       Impact factor: 84.694

8.  Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection.

Authors:  Robert E Lanford; Elisabeth S Hildebrandt-Eriksen; Andreas Petri; Robert Persson; Morten Lindow; Martin E Munk; Sakari Kauppinen; Henrik Ørum
Journal:  Science       Date:  2009-12-03       Impact factor: 47.728

9.  Control by pulse parameters of DNA electrotransfer into solid tumors in mice.

Authors:  M Cemazar; M Golzio; G Sersa; P Hojman; S Kranjc; S Mesojednik; M-P Rols; J Teissie
Journal:  Gene Ther       Date:  2009-02-12       Impact factor: 5.250

10.  Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma.

Authors:  Adil I Daud; Ronald C DeConti; Stephanie Andrews; Patricia Urbas; Adam I Riker; Vernon K Sondak; Pamela N Munster; Daniel M Sullivan; Kenneth E Ugen; Jane L Messina; Richard Heller
Journal:  J Clin Oncol       Date:  2008-11-24       Impact factor: 44.544

View more
  12 in total

1.  MicroRNAs and cancer: Key paradigms in molecular therapy.

Authors:  Weige Tan; Bodu Liu; Shaohua Qu; Gehao Liang; Wei Luo; Chang Gong
Journal:  Oncol Lett       Date:  2017-12-19       Impact factor: 2.967

2.  Circ_0015756 promotes proliferation, invasion and migration by microRNA-7-dependent inhibition of FAK in hepatocellular carcinoma.

Authors:  Ling Liu; Xin Yang; Nian-Feng Li; Ling Lin; Hui Luo
Journal:  Cell Cycle       Date:  2019-09-16       Impact factor: 4.534

3.  Silencing of miR-101 Prevents Cartilage Degradation by Regulating Extracellular Matrix-related Genes in a Rat Model of Osteoarthritis.

Authors:  Linghui Dai; Xin Zhang; Xiaoqing Hu; Qiang Liu; Zhentao Man; Hongjie Huang; Qingyang Meng; Chunyan Zhou; Yingfang Ao
Journal:  Mol Ther       Date:  2015-04-29       Impact factor: 11.454

Review 4.  MicroRNA-Based Therapeutics for Drug-Resistant Colorectal Cancer.

Authors:  Eunsun Jung; Jinhyeon Choi; Jang-Seong Kim; Tae-Su Han
Journal:  Pharmaceuticals (Basel)       Date:  2021-02-08

5.  MicroRNAs and intellectual disability (ID) in Down syndrome, X-linked ID, and Fragile X syndrome.

Authors:  Wei-Hong Siew; Kai-Leng Tan; Maryam Abbaspour Babaei; Pike-See Cheah; King-Hwa Ling
Journal:  Front Cell Neurosci       Date:  2013-04-15       Impact factor: 5.505

6.  Internalization of Locked Nucleic Acids/DNA Hybrid Oligomers into Escherichia coli.

Authors:  German M Traglia; Carol Davies Sala; Juan I Fuxman Bass; Alfonso J C Soler-Bistué; Angeles Zorreguieta; María Soledad Ramírez; Marcelo E Tolmasky
Journal:  Biores Open Access       Date:  2012-10

7.  Sub-cellular temporal and spatial distribution of electrotransferred LNA/DNA oligomer.

Authors:  Julie Orio; Elisabeth Bellard; Houda Baaziz; Chantal Pichon; Peter Mouritzen; Marie-Pierre Rols; Justin Teissié; Muriel Golzio; Sophie Chabot
Journal:  J RNAi Gene Silencing       Date:  2013-03-15

8.  Delivery of RNAi-Based Oligonucleotides by Electropermeabilization.

Authors:  Sophie Chabot; Sandrine Pelofy; Justin Teissié; Muriel Golzio
Journal:  Pharmaceuticals (Basel)       Date:  2013-04-10

9.  MicroRNA miR-124 controls the choice between neuronal and astrocyte differentiation by fine-tuning Ezh2 expression.

Authors:  Wen Hao Neo; Karen Yap; Suet Hoay Lee; Liang Sheng Looi; Piyush Khandelia; Sheng Xiong Neo; Eugene V Makeyev; I-hsin Su
Journal:  J Biol Chem       Date:  2014-07-25       Impact factor: 5.157

Review 10.  The Impact of Adipose Tissue-Derived miRNAs in Metabolic Syndrome, Obesity, and Cancer.

Authors:  Gabriella Simões Heyn; Luís Henrique Corrêa; Kelly Grace Magalhães
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-06       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.